431 related articles for article (PubMed ID: 12492729)
1. Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?
Gisbert JP; Jones EA; Pajares JM; Moreno-Otero R
Aliment Pharmacol Ther; 2003 Jan; 17(1):17-27. PubMed ID: 12492729
[TBL] [Abstract][Full Text] [Related]
2. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.
Michieletti P; Wanless IR; Katz A; Scheuer PJ; Yeaman SJ; Bassendine MF; Palmer JM; Heathcote EJ
Gut; 1994 Feb; 35(2):260-5. PubMed ID: 8307480
[TBL] [Abstract][Full Text] [Related]
3. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?
Sánchez-Pobre P; Castellano G; Colina F; Dominguez P; Rodriguez S; Canga F; Herruzo JA
J Clin Gastroenterol; 1996 Oct; 23(3):191-8. PubMed ID: 8899500
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis?
Colombato LA; Alvarez F; Côté J; Huet PM
Gastroenterology; 1994 Dec; 107(6):1839-43. PubMed ID: 7958699
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid.
Li CP; Tong MJ; Hwang SJ; Luo JC; Co RL; Tsay SH; Chang FY; Lee SD
J Gastroenterol Hepatol; 2000 Jan; 15(1):95-8. PubMed ID: 10719755
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical differences in the portal tract and acinar infiltrates between primary biliary cirrhosis and autoimmune cholangitis.
O'Donohue J; Wong T; Portmann B; Williams R
Eur J Gastroenterol Hepatol; 2002 Oct; 14(10):1143-50. PubMed ID: 12362106
[TBL] [Abstract][Full Text] [Related]
7. Primary Biliary Cholangitis and Autoimmune Hepatitis.
Gonzalez RS; Washington K
Surg Pathol Clin; 2018 Jun; 11(2):329-349. PubMed ID: 29751878
[TBL] [Abstract][Full Text] [Related]
8. [Autoimmune cholangitis or primary biliary cirrhosis without antimitochondrial antibodies?].
Saló J; Caballería L; Bruguera M; Parés A; Rodés J
Gastroenterol Hepatol; 1997 Jan; 20(1):5-10. PubMed ID: 9072202
[TBL] [Abstract][Full Text] [Related]
9. Negative conversion of antimitochondrial antibody in primary biliary cirrhosis: a case of autoimmune cholangitis.
Cho YJ; Han DS; Kim TY; Jang SJ; Jeon YC; Sohn JH; Lee IH; Park KN
J Korean Med Sci; 1999 Feb; 14(1):102-6. PubMed ID: 10102534
[TBL] [Abstract][Full Text] [Related]
10. Antimitochondrial antibody-negative primary biliary cirrhosis.
Lacerda MA; Ludwig J; Dickson ER; Jorgensen RA; Lindor KD
Am J Gastroenterol; 1995 Feb; 90(2):247-9. PubMed ID: 7847294
[TBL] [Abstract][Full Text] [Related]
11. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
[TBL] [Abstract][Full Text] [Related]
12. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
13. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.
Liu B; Shi XH; Zhang FC; Zhang W; Gao LX
Liver Int; 2008 Feb; 28(2):233-9. PubMed ID: 18251980
[TBL] [Abstract][Full Text] [Related]
14. Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis.
Taylor SL; Dean PJ; Riely CA
Am J Surg Pathol; 1994 Jan; 18(1):91-9. PubMed ID: 8279631
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous occurrence of chronic non-suppurative destructive cholangitis and antimitochondrial autoantibodies in MRL/lpr mice: possible animal model for primary biliary cirrhosis.
Tsuneyama K; Nose M; Nisihara M; Katayanagi K; Harada K; Nakanuma Y
Pathol Int; 2001 Jun; 51(6):418-24. PubMed ID: 11422802
[TBL] [Abstract][Full Text] [Related]
16. Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: Is It Really the Same Disease?
Chascsa DM; Lindor KD
Clin Liver Dis; 2018 Aug; 22(3):589-601. PubMed ID: 30259855
[TBL] [Abstract][Full Text] [Related]
17. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
[TBL] [Abstract][Full Text] [Related]
18. Management of primary biliary cirrhosis and autoimmune cholangitis.
Angulo P; Lindor KD
Clin Liver Dis; 1998 May; 2(2):333-51, ix. PubMed ID: 15560036
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune cholangitis syndrome with a bias towards primary biliary cirrhosis.
Omagari K; Ikuno N; Matsuo I; Shirono K; Hara K; Feeney SJ; Whittingham S; Mackay IR
Pathology; 1996 Aug; 28(3):255-8. PubMed ID: 8912357
[TBL] [Abstract][Full Text] [Related]
20. Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid.
Lee YM; Kaplan MM
Curr Gastroenterol Rep; 1999; 1(1):38-41. PubMed ID: 10980925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
